CompletedPhase 2NCT00096213
S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
Studying Chondrosarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- SWOG Cancer Research Network
- Principal Investigator
- R. Lor Randall, MD, FACSUniversity of Utah
- Intervention
- conventional surgery(procedure)
- Enrollment
- 60 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2009
Study locations (23)
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora, Colorado, United States
- University of Florida Shands Cancer Center, Gainesville, Florida, United States
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
- William Beaumont Hospital - Royal Oak Campus, Royal Oak, Michigan, United States
- University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, United States
- Akron City Hospital, Akron, Ohio, United States
- Oregon Health & Science University Cancer Institute, Portland, Oregon, United States
- Presbyterian Hospital of Dallas, Dallas, Texas, United States
- Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah, United States
- St. Joseph Cancer Center, Bellingham, Washington, United States
- Olympic Hematology and Oncology, Bremerton, Washington, United States
- Skagit Valley Hospital Cancer Care Center, Mount Vernon, Washington, United States
- Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
- Harborview Medical Center, Seattle, Washington, United States
- +8 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · American College of Surgeons
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00096213 on ClinicalTrials.govOther trials for Chondrosarcoma
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNANCT07360964Clear Cell Chondrosarcoma in ItalyIstituto Ortopedico Rizzoli
- RECRUITINGNCT07315542Diagnostic and Therapeutic Targets in Cartilaginous TumoursSt. Anne's University Hospital Brno, Czech Republic
- RECRUITINGEARLY PHASE1NCT06645808PET-imaging of Two Vartumabs in Patients With Solid TumorsVar2 Pharmaceuticals
- RECRUITINGPHASE3NCT06127407Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment RegimenServier Bio-Innovation LLC
- RECRUITINGNCT06486506Proximal Femur Reconstruction Following Resection of Primary Bone Tumors: Analysis of the Clinical and Radiographic ResultsCostantino Errani
- RECRUITINGPHASE2NCT06176989Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base TumorsNational Cancer Institute (NCI)
- RECRUITINGNANCT06387485A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative PlanningRicoh USA, Inc.
- ACTIVE NOT RECRUITINGPHASE2NCT05836571Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People >= 18 Years Old With Advanced Soft Tissue SarcomaNational Cancer Institute LAO